Oseltamivir recalls
The FDA has published 3 recalls involving Oseltamivir since 2021. The latest was reported on 28 Feb 2024. Most were for potency & assay. Amneal Pharmaceuticals of New York has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls3since 2021
Last 12 months0reported
Class I00% of total
Ongoing0latest 28 Feb 2024
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 67%Class III 1 33%
Why oseltamivir is recalled
Companies
Brands
By year
All oseltamivir recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Oseltamivir Phosphate for Oral Suspension 6mg/ml (reconstituted) recalledOseltamivir Phosphate | Amneal Pharmaceuticals of New York | Potency & Assay | Nationwide |
| Drug | CLASS II | Oseltamivir Phosphate for Oral Suspension 6 mg/mL* *Each mL recalledOseltamivir Phosphate For Oral Suspension | Cardinal Health | Manufacturing (CGMP) Deviations | FL, GA, SC |
| Drug | CLASS III | Oseltamivir Phosphate for Oral Suspension, 6 mg/mL recalledOseltamivir Phosphate | Lupin Pharmaceuticals | Potency & Assay | Nationwide |
Should you stop taking Oseltamivir?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.